丁苯肽与马来酸桂哌奇特注射液联用治疗急性脑梗死  

Clinical study on treatment of acute cerebral infarction with dl-3-budylphthalinde and cinepazide maleate

作　　者：刘明伟[1] 陆爽[1] 林昕[1] 李祎[1] 

机构地区：[1]云南省昆明市延安医院急诊科,昆明650051

出　　处：《实用药物与临床》2010年第2期101-102,共2页Practical Pharmacy and Clinical Remedies

摘　　要：目的评价丁苯肽与马来酸桂哌齐特联用治疗急性脑梗死的疗效。方法选择105例急性脑梗死的患者,随机分为3组,治疗组、丁苯肽组和对照组各35例。对照组予以常规治疗,治疗组在常规治疗的基础上加用丁苯肽、马来酸桂哌齐特,丁苯肽组仅给予丁苯肽治疗。在治疗前和治疗后1个月,分别进行神经功能缺损评分。结果治疗组对神经功能缺损的治疗效果优于桂哌奇特组及对照组。结论丁苯肽和马来酸桂哌齐特联用治疗急性脑梗死疗效确切。Objective To evaluate the curative effect of dl-3-budylphthalinde and cinepazide maleate on acute cerebral infarction.Methods 105 patients with acute cerebral infarction were divided into three groups randomly：control group（35 cases）,therapy group（35 cases）,budylphthalinde group（35 cases）.Patients in control group were treated by conventional treatment,and those in therapy group were treated with dl-3-budylphthalinde and cinepazide maleate,and patients in budylphthalinde group were treated with dl-3-budylphthalinde besides conventional treatment.Neurologic impairment score was tested before therapy and after four weeks treatment.Results There were significant differences in neurologic impairment score between the two groups.Conclusion The curative effect of dl-3-budylphthalinde and cinepazide maleate on acute cerebral infarction is accurative.

关 键 词：丁苯肽 马来酸桂哌齐特 脑梗死 

分 类 号：R743.3[医药卫生—神经病学与精神病学]